Dexterra Valuation
| HZNOF Stock | USD 5.57 0.36 6.91% |
At this time, the firm appears to be undervalued. Dexterra Group shows a prevailing Real Value of $6.27 per share. The current price of the firm is $5.57. Our model computes the value of Dexterra Group from reviewing the firm fundamentals such as Profit Margin of 0.01 %, shares outstanding of 65.23 M, and Current Valuation of 335.86 M as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Dexterra's price fluctuation is not too volatile at this time. Calculation of the real value of Dexterra Group is based on 3 months time horizon. Increasing Dexterra's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Dexterra pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Dexterra Group. Since Dexterra is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Dexterra Pink Sheet. However, Dexterra's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.57 | Real 6.27 | Hype 5.57 | Naive 5.73 |
The real value of Dexterra Pink Sheet, also known as its intrinsic value, is the underlying worth of Dexterra Group Company, which is reflected in its stock price. It is based on Dexterra's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Dexterra's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Dexterra Group helps investors to forecast how Dexterra pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dexterra more accurately as focusing exclusively on Dexterra's fundamentals will not take into account other important factors: Dexterra Total Value Analysis
Dexterra Group is currently estimated to have takeover price of 335.86 M with market capitalization of 273.54 M, debt of 65.32 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dexterra fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
335.86 M | 273.54 M | 65.32 M |
Dexterra Investor Information
About 50.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.19. Some equities with similar Price to Book (P/B) outperform the market in the long run. Dexterra Group last dividend was issued on the 29th of December 2022. The entity had 1:5 split on the 16th of July 2020. Based on the key measurements obtained from Dexterra's financial statements, Dexterra Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Dexterra Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dexterra has an asset utilization ratio of 137.97 percent. This implies that the Company is making $1.38 for each dollar of assets. An increasing asset utilization means that Dexterra Group is more efficient with each dollar of assets it utilizes for everyday operations.Dexterra Ownership Allocation
Dexterra holds a total of 65.23 Million outstanding shares. Dexterra Group retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Dexterra Profitability Analysis
The company reported the revenue of 733.38 M. Net Income was 24.36 M with profit before overhead, payroll, taxes, and interest of 101.64 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Dexterra's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Dexterra and how it compares across the competition.
About Dexterra Valuation
The pink sheet valuation mechanism determines Dexterra's current worth on a weekly basis. Our valuation model uses a comparative analysis of Dexterra. We calculate exposure to Dexterra's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dexterra's related companies.Dexterra Group Inc. provides support services for the creation, management, and operation of infrastructure in Canada. Dexterra Group Inc. was founded in 1985 and is headquartered in Mississauga, Canada. Dexterra operates under Specialty Business Services classification in the United States and is traded on OTC Exchange. It employs 6248 people.
8 Steps to conduct Dexterra's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Dexterra's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Dexterra's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Dexterra's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Dexterra's revenue streams: Identify Dexterra's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Dexterra's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Dexterra's growth potential: Evaluate Dexterra's management, business model, and growth potential.
- Determine Dexterra's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Dexterra's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Dexterra Growth Indicators
Investing in growth stocks can be very risky. If the company such as Dexterra does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 65.2 M | |
| Quarterly Earnings Growth Y O Y | -0.337 | |
| Forward Price Earnings | 9.0992 | |
| Retained Earnings | 69.6 M |
Complementary Tools for Dexterra Pink Sheet analysis
When running Dexterra's price analysis, check to measure Dexterra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dexterra is operating at the current time. Most of Dexterra's value examination focuses on studying past and present price action to predict the probability of Dexterra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dexterra's price. Additionally, you may evaluate how the addition of Dexterra to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |